Third international symposium on drug-impaired driving

Third international symposium on drug-impaired driving

Date and place: 
23 October 2017, Lisbon

Image for introduction: 

Introduction: 

The Third international symposium on drug-impaired driving is taking place on 23 October 2017 in Lisbon immediately prior to the Second European conference on addictive behaviours and dependencies (24-26 October). The symposium is a collaborative effort between the EMCDDA, the Canadian Centre on Substance Abuse (CCSA) the US National Institute on Drug Abuse (NIDA) and the New Zealand Drug Foundation.

With cannabis use and policy evolving internationally, drug-impaired driving has become an increasingly relevant issue. This international symposium will put the spotlight on key developments relevant to road safety in recent years and highlight the implications of these for drug-impaired driving. The prevalence of drug-impaired driving has begun to rival that of alcohol-impaired driving in some parts of the world, resulting in a greater focus on the ability to detect drug-impaired drivers using roadside screening tools. Similarly, with the changes in cannabis policy, many jurisdictions are working towards or have already implemented laws that establish ‘per se’ limits for drug use. With these significant changes in mind, mobilisation of research and collaboration of efforts will help us to navigate this growing area of concern. The objective of the symposium is to bring together key stakeholders who have advanced the field — whether it be through detection technology, innovation in prevention or experience in developing new drug policy — to share their experiences and lessons learned and to develop next steps to effectively address drug-impaired driving. This symposium will offer participants the opportunity to learn about the latest developments in the field, highlight new research and identify gaps still needing attention.

Label: 
Registration

Text: 

Online registration is now open.

Entry to the ‘3rd international symposium on drug–impaired driving’ is free of charge, but registration is required and on a first come, first served basis.

For administrative questions, please contact Helder.Carvalho@abreu.pt. For other questions, please contact drugsdriving@emcdda.europa.eu.
 

Label: 
Organisers

Text: 

The symposium is a collaborative effort between the Canadian Centre on Substance Abuse (CCSA), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the US National Institute on Drug Abuse (NIDA) and the New Zealand Drug Foundation.

Label: 
Confirmed speakers

Text: 

Vigdis Vindenes, Norway,
Head of Section ‘Drug Abuse Research’,
Oslo University Hospital

Jan Ramaekers, Netherlands,
Professor of Psychopharmacology and Behavioral Toxicology, Maastricht University

Kim Wolff, United Kingdom,
Professor of Addiction Science,
King’s College, London

Mário Dias, Portugal,
Senior Advisor in Forensic Toxicology, National Institute of Legal Medicine and Forensic Sciences

Barry Logan, USA,
Senior Vice President, Forensic Science Initiatives, Chief Scientist, NMS Labs

Doug Beirness, Canada,
Senior Research & Policy Analyst and Advisor, Canadian Centre on Substance Abuse

Darrin Grondel, USA,
Secretary, Governors Highway Safety Association (GHSA)

Label: 
Programme

Text: 

The symposium offers a unique opportunity to learn from what other countries are doing in terms of addressing drug-impaired driving and to network with international partners and facilitate potential collaboration. It will also highlight the implications and considerations for drug-impaired driving in the context of changing cannabis policy.

Topics may include:

  • Current state of the drug-impaired driving problem internationally and advances made since the 2014 symposium;
  • Legislation and policy, such as the importance of per se laws and the benefit of leveraging lessons learned from developing alcohol policy; Drug testing, including field impairment testing, such as the Drug Recognition Evaluator (DRE) program, oral fluid testing, breath testing for cannabis, and the implication of this technology for enforcement and adjudication;
  • Screening, assessment and rehabilitation for convicted drug-impaired drivers and the challenges of this population, including international examples;
  • Approaches to prevention such as targeted messaging incorporating perceptions among youth and strategies for creating an anti-drug-impaired driving culture (similar to alcohol); and
  • A special focus on cannabis-impaired driving, including Canada’s move towards a change in cannabis policy.

Label: 
Venue

Text: 

Venue

The Lisbon Congress Centre is located close to the river Tagus and the historical and cultural district of Belém, just a few minutes from the city centre, well
served by public transport. The ‘3rd international symposium on drug-impaired driving’ is taking place on 23 October in Lisbon
immediately prior to Lisbon Addictions 2017, the Second European conference on addictive behaviours and dependencies (24–26 October 2017).

Loading